Rejovac 35mg/5ml Oral Suspension

Introduction

Rejovac is a prescription medication that contains the active ingredient Silymarin. It is available in the form of an oral suspension and is used for various health conditions.

Uses

Rejovac is primarily prescribed for the treatment of liver disorders such as liver cirrhosis, hepatitis, and fatty liver disease. It is also used as a supportive therapy in individuals with liver damage caused by alcohol, drugs, or toxins.

Dosage and Administration

The dosage and administration of Rejovac should be determined by your healthcare provider based on your specific medical condition and response to treatment. Follow their instructions carefully.

Typically, the recommended dosage for adults is 10-20 ml of the suspension, taken 2-3 times daily. For children, the dosage may vary depending on their age and weight. It is advisable to shake the bottle well before each use and use the provided measuring device for accurate dosing.

Mechanism of Action

Silymarin, the active ingredient in Rejovac, is derived from the milk thistle plant. It is known for its hepatoprotective properties, meaning it helps protect and support the health of the liver. Silymarin exerts its effects by acting as an antioxidant and anti-inflammatory agent, helping to reduce liver inflammation and protect liver cells from damage.

Side Effects

Common side effects may include gastrointestinal disturbances such as nausea, stomach upset, and diarrhea. These side effects are usually mild and temporary.

In rare cases, serious side effects may occur, such as allergic reactions, including rash, itching, and swelling. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Rejovac may interact with certain medications, including anticoagulants (blood thinners), antiplatelet drugs, and drugs that are metabolized by the liver.

These interactions can affect the effectiveness and safety of both Rejovac and the other medications you are taking. Your healthcare provider will carefully evaluate the potential risks and benefits before prescribing Rejovac.

Precautions

Before using Rejovac, inform your healthcare provider about any pre-existing medical conditions you have, especially if you have a history of allergies, liver disease, or bleeding disorders.

Additionally, avoid alcohol consumption while taking Rejovac, as alcohol can further damage the liver and reduce the effectiveness of the medication.

Storage

Rejovac should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and out of reach of children. Do not freeze the medication.

Patient Tips

• Take Rejovac as prescribed by your healthcare provider. Do not exceed the recommended dosage.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about the medication, do not hesitate to contact your healthcare provider or pharmacist.
• maintain a healthy lifestyle, including a balanced diet and regular exercise, to support the health of your liver.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Milk Thistle Uses, Benefits & Dosage Herbal Database (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• Hepatitis C and Dietary Supplements (National Center for Complementary and Integrative Health) [Accessed 16 Jun. 2024] (online) Available at:
• Federico A, Dallio M, Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules. 2017 Jan 24;22(2):191. doi: 10.3390/molecules22020191. [Accessed 13 Jun. 2024] Available at:
• Zholobenko A, Modriansky M. Silymarin and its constituents in cardiac preconditioning. Fitoterapia. 2014 Sep;97:122-32. doi: 10.1016/j.fitote.2014.05.016. Epub 2014 May 29. [Accessed 27 Jun. 2024] Available at: